These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7360368)

  • 1. [Cyclophosphamide, methotrexate and 5-fluorouracil (CMF), versus 5-fluorouracil, in carcinoma of the large intestine in an advanced stage].
    Scanni A; Tomirotti M; Biraghi M; Annibali E; Del Bianco S
    Minerva Med; 1980 Mar; 71(10):799-801. PubMed ID: 7360368
    [No Abstract]   [Full Text] [Related]  

  • 2. [CMF (cyclophosphamide, methotrexate, ftorafur) chemotherapy in advanced breast cancer].
    Gottwald G; Szakolczai I
    Orv Hetil; 1983 Jan; 124(2):79-84. PubMed ID: 6687491
    [No Abstract]   [Full Text] [Related]  

  • 3. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
    Mouridsen HT; Palshof T; Engelsman E; Sylvester R
    Eur J Cancer (1965); 1980; Suppl 1():119-23. PubMed ID: 7032921
    [No Abstract]   [Full Text] [Related]  

  • 4. ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb2 overexpression and with p21Cip1 overexpression.
    Yang W; Klos KS; Zhou X; Yao J; Yang Y; Smith TL; Shi D; Yu D
    Cancer; 2003 Sep; 98(6):1123-30. PubMed ID: 12973835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.
    Bellon JR; Shulman LN; Come SE; Li X; Gelman RS; Silver BJ; Harris JR; Recht A
    Cancer; 2004 Apr; 100(7):1358-64. PubMed ID: 15042668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trial.
    Pannuti F; Lelli G; Casadio M; Piana E; Di Marco AR
    Cancer Treat Rep; 1980; 64(10-11):1131-4. PubMed ID: 7459899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the combination of BCNU, VCR and 5-FU in the treatment of disseminated neoplasms of the large intestine].
    Luporini G; Labianca R; Fraschini P; Tedeschi L
    Minerva Med; 1980 Mar; 71(10):773-9. PubMed ID: 7360363
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of polychemotherapy in the advanced stages of cervico-facial tumors].
    Fazio M; Vercellino V; Cavallero P; Sartoris S; Rodino A; Salassa B
    Minerva Stomatol; 1978; 27(1):23-7. PubMed ID: 277751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of 5-fluorouracil chemotherapy in malignant neoplasms of the large intestine].
    Salama A; Cafoncelli A
    Prensa Med Argent; 1965 Oct; 52(36):2294-5. PubMed ID: 5879676
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer.
    Coskun U; Gunel N; Onuk E; Yilmaz E; Bayram O; Yamac D; Cihan A; Ucan B; Yildirim Y; Celenkoglu G; Ozkan S
    Neoplasma; 2003; 50(3):210-6. PubMed ID: 12937855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficiency and side effects of adriamycin-cyclophosphamide therapy compared to a triple combination of cyclophosphamide, methotrexate and 5-fluoro-uracil].
    Weymar P; Schulz KD; Noldus B; Schmidt-Rhode P
    Arch Gynecol; 1979 Jul; 228(1-4):445-6. PubMed ID: 485425
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of metastasizing solid tumors with cyclophosphamide, methotrexate, vincristine and 5-fluorouracil].
    Fritsch H; Castor H; Drings P; Moskwa G
    Verh Dtsch Ges Inn Med; 1973; 79():1373-6. PubMed ID: 4790188
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
    Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endolymphatic polychemotherapy of cancer of the ovaries].
    Pankov AK; Sidorenko IuS; Il'inskaia EG; Birbraer VM
    Vopr Onkol; 1975; 21(4):55-7. PubMed ID: 812260
    [No Abstract]   [Full Text] [Related]  

  • 15. [Late results of the prophylactic treatment with 5-fluorouracil of cancer of the large intestine and rectum].
    Blokhina NG
    Klin Med (Mosk); 1976 Aug; 54(8):58-63. PubMed ID: 1011775
    [No Abstract]   [Full Text] [Related]  

  • 16. Quadruple chemotherapy in the treatment of advanced or recurrent gastrointestinal carcinoma.
    Cheng FC; Lee CM; Ong GB
    Clin Oncol; 1977 Jun; 3(2):191-5. PubMed ID: 872473
    [No Abstract]   [Full Text] [Related]  

  • 17. New concepts in chemotherapy of advanced gastrointestinal cancer.
    Oberfield RA; Sullivan RD
    Lahey Clin Found Bull; 1967; 16(2):197-205. PubMed ID: 4227052
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Five years treatment of advanced solid malignomas with a combination of four cytostatic drugs (author's transl)].
    Siebner H; Weber W
    Osterr Z Onkol; 1976 May; 3(1-2):8-26. PubMed ID: 1036616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil in operable breast carcinoma.
    Falo C; Moreno A; Benito E; Lloveras B; Varela M; Serra JM; Prieto L; Azpeitia D; Escobedo A
    Cancer; 2005 Feb; 103(4):657-63. PubMed ID: 15648085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.